When technical information slows a business enquiry, we organise your positioning, reviewed product content and contact process for appropriate professional audiences.
5 questions. No signup. Get your plan instantly.
A self-assessment to shape your brief. You choose whether to take it further.
Pick the problem that sounds like your pharma & medtech business. Each one shows how we fix it, what changes for you and how long it takes.
“The website has no product catalogue”
Buyers and partners search online for manufacturers, but the website lacks product lists, certifications and a clear enquiry route.
You get: More qualified B2B and export enquiries
5–8 weeks.
“Material is used without medical review”
Promotional material is created without a clear review process, risking non-compliant claims under UCPMP and other codes.
You get: Lower compliance risk
4–6 weeks.
“Reps create their own material”
Representatives use outdated brochures and personal WhatsApp forwards, so messaging is inconsistent and sometimes non-compliant.
You get: Consistent, compliant messaging
4–6 weeks.
“Slow distributor onboarding”
Distributors lack product information and brand guidance, and new territories are hard to develop.
You get: Faster territory expansion
4–5 weeks.
“The corporate website is outdated”
The company is known only to existing buyers. Investors, recruits and the media find little credible information.
You get: Stronger investor and partner confidence
6–8 weeks.
“Launch material arrives late”
New products launch with incomplete material, unclear positioning and a field force that is not ready.
You get: Faster, coordinated launches
6–10 weeks before launch.
Brand, communication and reputation planned together.
Separate briefs for pharma manufacturers and medtech companies and more.
Published up front. Scope confirmed before commitment.
Clarify, connect, then review with evidence.
PharmaBrandX is a pharma & medtech branding and communication agency for pharmaceutical companies, medtech firms, API makers and distributors. Evidence before expression.
Posts, videos, pages and ads are deliverables. The engagement is about one thing: more of an approved, traceable publication.
Teams use different claims, and the supporting evidence, approved wording and current asset version are hard to trace.
A product-specific claim-to-source register, an approved messaging library, audience-appropriate content, version control, a reviewer workflow and a process to withdraw outdated material.
Managing scientific content with traceable evidence and a responsible publication process, with qualified reviewers.
We compare like-for-like periods, so you see what actually changed—not just what went up.
Every stage is a place buyers and partners can be lost. We look at the whole path—not just the ads at the top.
Most pharma & medtech businesses spend at the top of the funnel but lose people at contact and qualify. Find your leak in two minutes
Anyone can generate a logo, a post or a landing page in minutes. What moves a pharma & medtech business is judgement, accountability and knowing the rules of the industry.
Select your business type to see the priorities, deliverables and customer journey we would consider.
Keep product and corporate communication within an approved scope.
See the approach 02 / Business typeExplain the product and intended use clearly.
See the approach 03 / Business typeHelp trade partners find the right approved information.
See the approach 04 / Business typeMake a complex service easier to evaluate.
See the approachClaim registers, review ownership and controlled templates. That is a different brief from life-science services, where the work begins with capability positioning, technical material and appropriate B2B handoffs.
We scope the work around the audience, your existing assets and the team that will handle the next step. The outcome is a practical programme you can inspect—not a list of disconnected activities.
Answer eight quick questions written for pharma & medtech businesses. Get a score, your weakest area and the first three things to fix.
A brand people understand. Communication with a purpose. Trust supported by accurate information and real experiences.
Corporate and product hierarchy · Evidence-friendly visual system · Approved product template library.
02Reviewed B2B product content · Intended-use information design · Trade and distributor enquiry journeys.
03Claim and version register · Medical and regulatory approval workflow · Public-information correction process.
Illustrative design studies—not past client campaigns or claimed performance results.
Corporate and product hierarchy, supported by evidence-friendly visual system.
Reviewed product or capability material, with explicit ownership and a record of what happens next.
Verify the context. Approve the response. Move sensitive matters privately.
Claim and version register, linked to medical and regulatory approval workflow.
These are the stages we design around. Open the interactive map to inspect the work and handoff.
Confirm audience, intended use and permitted communication scope.
Approved communication briefMap claims to current approved supporting information.
Evidence and version registerDesign clear materials for the approved audience.
Reviewed product or capability materialRoute appropriate business enquiries to the relevant team.
B2B enquiry and document handoffIndustry expertise is the part a generic agency or an AI tool cannot fake. Every claim we help publish is checked against these first.
Pointers for review, not legal advice. Specialist sign-off is arranged where your claims need it.
Use this to judge any provider—including us.
Not results we cannot control—the way we work, written down.
Deliverables, quantities, revisions, timeline and exclusions are agreed in writing first.
Domains, ad accounts, profiles and final assets stay in your name, with role-based access for us.
We never buy or incentivise reviews, inflate numbers or promise positions we cannot control.
Every factual or professional claim is checked against your evidence and industry rules first.
Review the evidence together, then continue, change or stop—no lock-in beyond the agreed scope.
Final files, usage guide, access record and next priorities, even if you stop working with us.
Choose the type of help you need. Each engagement is standalone; scope is confirmed before any commitment.
Not sure what is really holding the business back? Start with an evidence-backed diagnosis and a clear priority.
One customer journey is losing enquiries or customers. We implement the fix—pages, handoff, supported integrations and staff process.
Keep the fixed journey working: monitoring, updates, workflow maintenance, suitable experiments and honest reporting.
Proposed planning fees, not a binding quotation. Media spend, applicable taxes, software, on-site shoots, travel, custom development and specialist review are additional unless explicitly agreed. No sales, ranking or conversion guarantees.
Start with a practical guide. No email wall or invented score.
A practical checklist for positioning, approved information and a consistent first impression.
Read the guide Field guide / 02Questions to ask before adding more traffic, campaigns or contact channels.
Read the guide Field guide / 03A workable response, permission and escalation structure—not a promise of five-star reviews.
Read the guidePharmaBrandX is a pharma & medtech branding and communication agency for pharmaceutical companies, medtech firms, API makers and distributors. It combines three connected services: branding, reviewed communication, reputation. Brand systems, approved product information and B2B communication for pharma and medtech teams. Build clarity around evidence, intended use and responsible review.
Proposed starting fees are ₹40,000 one-time for Diagnose the problem, ₹65,000 one-time for Fix my claim-approval workflow, and ₹1,20,000 per month for Operate & improve. These are planning fees, not binding quotations; taxes, media spend and third-party costs are extra unless agreed.
PharmaBrandX works with pharma manufacturers, medtech companies, distributors, life-science services. Each business type starts from a different brief: for example, pharma manufacturers need claim registers, review ownership and controlled templates.
A first phase typically follows a 90-day rhythm: days 1–30 clarify the brief and establish direction, days 31–60 connect the page, content and handoff, and days 61–90 review evidence and decide the next phase. Exact timing depends on scope, asset readiness and approvals.
Review of your agreed records and current customer journey; Customer questions, objections and alternatives reviewed; A baseline for approval turnaround and unsupported claims caught; Positioning and messaging recommendation; An evidence-backed diagnosis: priorities and what can wait; A clear, written scope for the fix. Scope, inputs and timing are agreed in writing first.
No. Reviews are requested neutrally and never purchased or incentivised, and no ranking, enquiry or revenue outcome is guaranteed. The work focuses on accurate information, a useful customer journey and a responsible response process.
Yes—content and first ideas you can generate yourself with AI. That is not the main value of the service. We learn how your business actually works, then connect the right message, real information, a working enquiry process and team follow-up, and check against agreed records what improved. If you only need files, the scope is different. If you need a customer journey that is implemented and maintained, that is what we do.
The action that matters for pharma & medtech: an approved, traceable publication. Reporting follows the chain Approval turnaround → Unsupported claims caught → Outdated assets corrected—not impressions or form counts alone. Linking a result to a campaign is not proof the campaign caused it, so comparison periods and data limits are explained.
Prescription medicines should not be promoted to the public, and certain disease claims are prohibited outright. Corporate information, capabilities and approved product information for professionals are possible with medical and regulatory review.
The Uniform Code for Pharmaceutical Marketing Practices sets expectations for how pharmaceutical companies promote products and engage healthcare professionals, including evidence-based claims and restrictions on gifts and hospitality.
Fix the gap closest to the customer’s decision. If people cannot tell what you offer, start with brand clarity. If they understand but do not act, improve the customer journey from define to explain. If they hesitate because of trust, start with information accuracy and feedback handling. The free project planner recommends a starting point in five questions.
Tell us about the business, the gap and the work you need. Start with a useful brief—not a bigger package.
